Group One Trading’s Neurotrope, Inc. Common NTRP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-10,600
Closed -$12K 7295
2020
Q3
$12K Sell
10,600
-9,700
-48% -$11.2K ﹤0.01% 5370
2020
Q2
$24K Sell
20,300
-5,500
-21% -$6.88K ﹤0.01% 4755
2020
Q1
$21K Buy
+25,800
New +$28.1K ﹤0.01% 4218
2019
Q4
Sell
-13,700
Closed -$11K 5877
2019
Q3
$11K Buy
13,700
+4,000
+41% +$18.3K ﹤0.01% 4585
2019
Q2
$78K Sell
9,700
-48,400
-83% -$325K ﹤0.01% 3535
2019
Q1
$317K Buy
+58,100
New +$250K ﹤0.01% 2335
2018
Q2
Sell
-3,000
Closed -$24K 5665
2018
Q1
$24K Sell
3,000
-14,000
-82% -$111K ﹤0.01% 4018
2017
Q4
$120K Sell
17,000
-31,800
-65% -$185K ﹤0.01% 3256
2017
Q3
$252K Buy
48,800
+3,000
+7% +$15.7K ﹤0.01% 2598
2017
Q2
$429K Buy
+45,800
New +$489K ﹤0.01% 2085

Other funds holding NTRP

Group One Trading's NTRP Position: Q2 2020 in Review

Group One Trading sold out of Neurotrope, Inc. Common (NTRP) in Q2 2020, closing a stake of 9,037 shares — an estimated $11.3K sold.

Group One Trading first reported a position in NTRP in Q2 2017 and held it in 7 quarters. The position peaked at $222K in Q2 2017. 31 funds tracked by Wall St. Rank hold NTRP as of Q2 2020.

  • Group One Trading reported no remaining Neurotrope, Inc. Common position as of Q2 2020 after selling out during the quarter.
  • Group One Trading sold 9,037 Neurotrope, Inc. Common shares in Q2 2020, an estimated $11.3K.
  • Group One Trading first reported a position in Neurotrope, Inc. Common in Q2 2017 and held it in 7 quarters.
  • Group One Trading's Neurotrope, Inc. Common position peaked at $222K in Q2 2017.
  • 31 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q2 2020.

Based on Group One Trading's 13F filing for Q2 2020, filed 13 Aug 2020.